Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson’s Disease – Viewpoint

Dr Sportelli, Dr Urso and Prof Chaudhuri, of the National Parkinson Foundation International Centre of Excellence at King’s College London, discuss on Frontiers in Neurology, metformin’s neuroprotective potential by outlining relevant mechanisms of action and the selection of idiopathic rapid eye movement behaviour disorder patients for future clinical trials in Parkinson’s disease.